Cargando…

The Significant Reduction or Complete Eradication of Subcutaneous and Metastatic Lesions in a Pheochromocytoma Mouse Model after Immunotherapy Using Mannan-BAM, TLR Ligands, and Anti-CD40

Therapeutic options for metastatic pheochromocytoma/paraganglioma (PHEO/PGL) are limited. Here, we tested an immunotherapeutic approach based on intratumoral injections of mannan-BAM with toll-like receptor ligands into subcutaneous PHEO in a mouse model. This therapy elicited a strong innate immuni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caisova, Veronika, Li, Liping, Gupta, Garima, Jochmanova, Ivana, Jha, Abhishek, Uher, Ondrej, Huynh, Thanh-Truc, Miettinen, Markku, Pang, Ying, Abunimer, Luma, Niu, Gang, Chen, Xiaoyuan, Ghayee, Hans Kumar, Taïeb, David, Zhuang, Zhengping, Zenka, Jan, Pacak, Karel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562455/ https://www.ncbi.nlm.nih.gov/pubmed/31083581 http://dx.doi.org/10.3390/cancers11050654

Ejemplares similares

Identification of Immune Cell Infiltration in Murine Pheochromocytoma during Combined Mannan-BAM, TLR Ligand, and Anti-CD40 Antibody-Based Immunotherapy
por: Uher, Ondrej, et al.
Publicado: (2021)

Systemic Immune Response in Murine Bilateral Pheochromocytoma Model During Immunotherapy Based on a Combination of Mannan-BAM, TLR Ligands and Anti-CD40 Antibodies (MBTA Therapy)
por: Uher, Ondrej, et al.
Publicado: (2021)

Mannan-BAM, TLR Ligands, Anti-CD40 Antibody (MBTA) Vaccine Immunotherapy: A Review of Current Evidence and Applications in Glioblastoma
por: Lookian, Pashayar P., et al.
Publicado: (2021)

Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy
por: Uher, Ondrej, et al.
Publicado: (2023)

PSAT089 Lack of Effect of Metformin in Murine Pheochromocytoma Model
por: Ghayee, Hans K, et al.
Publicado: (2022)

Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and Paraganglioma
por: Liu, Yang, et al.
Publicado: (2020)

Hypoxia potentiates the cytotoxic effect of piperlongumine in pheochromocytoma models
por: Bullova, Petra, et al.
Publicado: (2016)

Novel Germline SUCLG2 Mutations in Patients With Pheochromocytoma and Paraganglioma
por: Vanova, Katerina Hadrava, et al.
Publicado: (2021)

Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
por: Pang, Ying, et al.
Publicado: (2017)

Pheochromocytoma (PHEO) and Paraganglioma (PGL)
por: Pacak, Karel, et al.
Publicado: (2019)

Deep Membrane Proteome Profiling Reveals Overexpression of Prostate-Specific Membrane Antigen (PSMA) in High-Risk Human Paraganglioma and Pheochromocytoma, Suggesting New Theranostic Opportunity
por: Vit, Ondrej, et al.
Publicado: (2021)

A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2(V617F) positive polycythemia vera: a case report
por: Pang, Ying, et al.
Publicado: (2018)

PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma
por: Hadrava Vanova, Katerina, et al.
Publicado: (2022)

BamBam: genome sequence analysis tools for biologists
por: Page, Justin T, et al.
Publicado: (2014)

rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses
por: Ye, Juan, et al.
Publicado: (2023)

Personalized Management of Pheochromocytoma and Paraganglioma
por: Nölting, Svenja, et al.
Publicado: (2021)

Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model
por: Caisová, Veronika, et al.
Publicado: (2016)

Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World
por: Patel, Mayank, et al.
Publicado: (2021)

MON-199 Targeting Pheochromocytoma/Paraganglioma with Polyamine Inhibitors
por: Ghayee, Hans Kumar, et al.
Publicado: (2020)

Performances of Functional and Anatomic Imaging Modalities in Succinate Dehydrogenase A-Related Metastatic Pheochromocytoma and Paraganglioma
por: Patel, Mayank, et al.
Publicado: (2022)

Improper Coordination of BamA and BamD Results in Bam Complex Jamming by a Lipoprotein Substrate
por: Tata, Muralidhar, et al.
Publicado: (2019)

New insights on the pathogenesis of paraganglioma and pheochromocytoma
por: Kantorovich, Vitaly, et al.
Publicado: (2018)

RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective
por: Crona, Joakim, et al.
Publicado: (2018)

BamA and BamD Are Essential for the Secretion of Trimeric Autotransporter Adhesins
por: Rooke, Jessica L., et al.
Publicado: (2021)

Lost in transition: Maize BAM7 is a dual function gene encoding a nuclear BAM7 and plastidial BAM2
por: Chen, Jiawen
Publicado: (2023)

ppBAM: ProteinPaint BAM track for read alignment visualization and variant genotyping
por: Paul, Robin, et al.
Publicado: (2023)

Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization
por: Vit, Ondrej, et al.
Publicado: (2023)

Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
por: Ilanchezhian, Maran, et al.
Publicado: (2020)

Pheochromocytoma and Paraganglioma: Current Functional and Future Molecular Imaging
por: Blanchet, Elise M., et al.
Publicado: (2012)

THU612 SDHx Pheochromocytoma/Paraganglioma Has Elevation Of Arginine And Lysine Metabolites
por: Ghayee, Hans Kumar, et al.
Publicado: (2023)

Plasticity within the barrel domain of BamA mediates a hybrid-barrel mechanism by BAM
por: Wu, Runrun, et al.
Publicado: (2021)

Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging
por: Alrezk, Rami, et al.
Publicado: (2018)

Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies
por: Pang, Ying, et al.
Publicado: (2019)

Succinate Mediates Tumorigenic Effects via Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas
por: Matlac, Dieter M., et al.
Publicado: (2021)

The Synthetic Phenotype of ΔbamB ΔbamE Double Mutants Results from a Lethal Jamming of the Bam Complex by the Lipoprotein RcsF
por: Hart, Elizabeth M., et al.
Publicado: (2019)

SUN-330 Non-Mosaic Somatic HIF2A Mutations Associated with Late-Onset Polycythemia-Paraganglioma Syndrome: Newly Recognized Subclass of Polycythemia-Paraganglioma Syndrome
por: Pang, Ying, et al.
Publicado: (2019)

Murine Models and Cell Lines for the Investigation of Pheochromocytoma: Applications for Future Therapies?
por: Korpershoek, Esther, et al.
Publicado: (2012)

quickBAM: a parallelized BAM file access API for high-throughput sequence analysis informatics
por: Pitman, Anders, et al.
Publicado: (2023)

Postoperative Management in Patients with Pheochromocytoma and Paraganglioma
por: Mamilla, Divya, et al.
Publicado: (2019)

Overproducing the BAM complex improves secretion of difficult-to-secrete recombinant autotransporter chimeras
por: Phan, Trang H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6vvda3bof7f18j2p2an46mp72d